Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Krishnan Ram R.Executive Vice Pres & COO | Grant or award | A | — 23.5K sh | Nov 4, 2026 |
| 17 | Puri Michal NathChief Human Resources Officer | Open-market sale | SELL | $8,738 660 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Bell Susan R.Director | Grant or award | A | — 15.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Stiefel Justin BDirector, CEO & Treasurer | Option exercise | M | — 1,458 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Binde Alana MSVP-Chief Human Resource Offcr | Grant or award | A | — 2,227 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Musa FernandoDirector, Executive Chairman | Grant or award | A | — 153.4K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Lenkowsky AdamEVP, Chief Commercial Officer | Tax withholding | F | $237K 3,848 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $150K 2,738 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Reed David L.EVP & CFO | Tax withholding | F | $81K 345 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $357K 1,160 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Daspit MarisaCHIEF PEOPLE OFFICER | Open-market sale · 10b5-1 plan | SELL | $36K 720 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $118K 295 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $164K 410 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Costello Beth AnnEVP and CFO | Option exercise · 10b5-1 plan | M | $1.70M 31.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Berry Jason MEVP & Chief Operating Officer | Tax withholding | F | $59K 1,540 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $176K 432 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fain Richard DDirector | Gift | G | — 5,605 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Turner KamiChief Accounting Officer | Option exercise | M | $101K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Kasbar Michael JDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $292K 8,062 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Bhutani Amanpal SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $530K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Vassil JonathanChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $373K 11.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $185K 3,094 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $212K 3,283 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $184K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $100K 240 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $127K 317 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Coloma Jason VDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $799K 26.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $134K 334 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Hovnanian Alexander A.President | Tax withholding | F | $229K 2,185 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | George Jennifer LSEVP and COO | Option exercise | M | $56K 2,110 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $1.96M 130.1K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Kossover AmyChief Accounting Officer | Tax withholding | F | $61K 10.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Nonko EugeneDirector | Open-market sale · 10b5-1 plan | SELL | $1.43M 93.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $81K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Southern Cross Acquisition II Sponsor Corp.10% Owner | Other acquisition or disposition | J | — 324.1K sh | Nov 4, 2026 traded Nov 2, 2026 |